Revance to Acquire HintMD in All-Stock Transaction.

MANews-(C)2009-2020

US-based biotechnology company Revance Therapeutics, Inc. (NASDAQ: RVNC) has agreed to acquire California-based Hint, Inc., (d/b/a HintMD), a financial technology platform for the aesthetics industry, in an all-stock transaction, the company said.

Revance has agreed to pay HintMD's shareholders a total of 8.54m shares of Revance common stock.

Additional terms were not disclosed. The transaction is expected to close in 3Q20, subject to customary closing conditions, including receipt of approval of the requisite HintMD stockholders.

The acquisition of HintMD would augment Revance's strong aesthetics product portfolio with a fintech platform to transform both the practice and...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT